BioAge Labs Statistics
Share Statistics
BioAge Labs has 35.85M
shares outstanding. The number of shares has increased by null%
in one year.
| Shares Outstanding | 35.85M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | 64.22% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 980 |
| FTD / Avg. Volume | 0.41% |
Short Selling Information
The latest short interest is 1.74M, so 4.86% of the outstanding
shares have been sold short.
| Short Interest | 1.74M |
| Short % of Shares Out | 4.86% |
| Short % of Float | 5.71% |
| Short Ratio (days to cover) | 10.28 |
Valuation Ratios
The PE ratio is -0.87 and the forward
PE ratio is -1.78.
BioAge Labs's PEG ratio is
0.04.
| PE Ratio | -0.87 |
| Forward PE | -1.78 |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 0.19 |
| P/FCF Ratio | -1.2 |
| PEG Ratio | 0.04 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for BioAge Labs.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.86,
with a Debt / Equity ratio of 0.03.
| Current Ratio | 12.86 |
| Quick Ratio | 12.86 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | -0.11 |
| Debt / FCF | -0.17 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-1,146,919.35 |
| Employee Count | 62 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by null% in the
last 52 weeks. The beta is 0.77, so BioAge Labs's
price volatility has been higher than the market average.
| Beta | 0.77 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 3.91 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 49.6 |
| Average Volume (20 Days) | 236,593 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -78.19M |
| Net Income | -71.11M |
| EBITDA | -78.19M |
| EBIT | -73.48M |
| Earnings Per Share (EPS) | -6.63 |
Full Income StatementBalance Sheet
The company has 354.35M in cash and 8.7M in
debt, giving a net cash position of 345.64M.
| Cash & Cash Equivalents | 354.35M |
| Total Debt | 8.7M |
| Net Cash | 345.64M |
| Retained Earnings | -252.81M |
| Total Assets | 343.84M |
| Working Capital | 301.07M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -51.52M
and capital expenditures -366K, giving a free cash flow of -51.89M.
| Operating Cash Flow | -51.52M |
| Capital Expenditures | -366K |
| Free Cash Flow | -51.89M |
| FCF Per Share | -4.84 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
